Pauls Matthew 4/A

4/A · Pelthos Therapeutics Inc. · Filed Apr 1, 2026

AI-generated summary of this filing

Updated Apr 1, 2026

Pelthos (PTHS) Director Pauls Matthew Receives 25,478-Share RSU Award

What Happened

Pauls Matthew, a director of Pelthos Therapeutics Inc. (PTHS), was granted 25,478 restricted stock units (RSUs) on July 2, 2025. The grant is reported as an acquisition (code A) at $0.00 per share (total reported value $0) because RSUs represent future stock settlement rather than an immediate cash purchase.
This Form 4 is an amendment to the original filing — the amendment reports the RSU grant in Table I (the original Form 4 reported the grant in Table II).

Key Details

Transaction date: July 2, 2025; Amendment filed with the SEC on April 1, 2026.
Grant: 25,478 RSUs; reported acquisition price: $0.00 per share (RSUs settle in shares upon vesting).
Shares owned after transaction: not specified in the amended filing.
Footnotes: (1) Each RSU represents the right to one share of Pelthos common stock and may be settled solely in shares. (2) Vesting: one-third vested on July 2, 2025; the remaining two-thirds vest in equal quarterly installments over the next two years, subject to continued service as a director.
Remarks: Exhibit 24 (Power of Attorney) is included with the filing.
Filing status: This is an amended Form 4 filed in 2026 to adjust how the original grant was reported; review the original Form 4 for initial timing details.

Context

RSU grants are a common form of director compensation and do not represent an open-market purchase or sale. They convey potential future ownership if the director remains in service and the RSUs vest; they are not immediate cash compensation.

Form 4/AAmended

Period: 2025-07-02

Director

Transactions

Footnotes (2)

[F1]Represents shares of common stock, par value $0.0001 per share ("Common Stock") of Pelthos Therapeutics Inc. (the "Issuer"), issuable upon settlement of restricted stock units of the Issuer ("RSUs") granted to the reporting person pursuant to the Issuer's 2023 Equity Incentive Plan, as amended from time to time (the "2023 Plan"), each of which represents the right to receive one (1) share of Common Stock, subject to the vesting terms of such RSUs, and may be settled solely in shares of Common Stock. The original grant of RSUs was reported in Table II of the Form 4 filed by the reporting person (the "Original Form 4"). This Form 4 amendment (this "Amendment") is being filed to amend the Original Form 4 in order to report the grant of such RSUs in Table I.
[F2]The RSUs were received as compensation for the reporting person's service as a member of the Issuer's board of directors pursuant to the 2023 Plan. The RSUs vest as follows: the initial one-third of shares vested on July 2, 2025, and the remainder vesting in equal installments on a quarterly basis thereafter over a period of two years, so long as the reporting person remains in the service of the Issuer on each such anniversary.

Signature

/s/ Francis Knuettel II, by power of attorney|2026-04-01

2 files